Clinical trial
Treatment Patterns and Clinical Outcomes Among Venous Thromboembolism Patients Treated With Anticoagulants After the Entry of Non-vitamin K Antagonist Oral Anticoagulants in Korea
NCT05022563 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment Patterns and Clinical Outcomes Among Venous Thromboembolism Patients Treated With Anticoagulants After the Entry of Non-vitamin K Antagonist Oral Anticoagulants in Korea
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2021
- Completion date
- September 30, 2021
- Enrollment
- 55,759 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.